Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID, GenArraytion Partner to Test Pathogen Detection Dx Assays

NEW YORK (GenomeWeb) – PositiveID today announced that they have signed an agreement to partner with Rockville, Maryland-based GenArraytion.

Under the terms of the agreement, PositiveID will evaluate GenArraytion's assays on its Firefly Dx PCR prototype pathogen detection system.

GenArraytion's MultiFlex Bioassays for pathogens can feature up to 20 DNA or RNA targets per panel, and are designed for use with real-time or bead-based platforms. The configurable, mix-and-match assays have been developed for clinical pathogens, veterinary pathogens, food- and water-borne pathogens, and biological threats.

Financial and other details of the agreement were not disclosed.

In May 2014, Del Ray Beach, Florida-based PositiveID signed a deal to develop military applications for the Firefly Dx system.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.